Progress in the development of childhood cancer therapy

Reproductive Toxicology

Volumn 22, Issue 2, 2006, Pages 126-132

  Garolla, Andrea ^a   Pizzato, Cristina ^a   Ferlin, Alberto ^a   Carli, Modesto Ottaviano ^a   Selice, Riccardo ^a   Foresta, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemotherapy; Childhood cancer; Male infertility; Testicular function

Indexed keywords

ALKYLATING AGENT; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ANEUPLOIDY; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; DISOMY; DOSE RESPONSE; GONADAL DISEASE; HUMAN; LEYDIG CELL; LONG TERM EXPOSURE; MALE; MALE INFERTILITY; PUBERTY; SPERMATOZOON COUNT; TESTIS FUNCTION; TESTIS SIZE; VARICOCELE;

ADOLESCENT; ANTINEOPLASTIC AGENTS, ALKYLATING; CHILD; CHILD, PRESCHOOL; CHROMOSOMES; CYCLOPHOSPHAMIDE; HUMANS; IFOSFAMIDE; MALE; NEOPLASMS; OLIGOSPERMIA; RETROSPECTIVE STUDIES; TESTIS;

EID: 33745621315     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2006.04.020     Document Type: Article

References (69)

1. Thomson A.B., Anderson R.A., Irvine D.S., Kelnar C.J., Sharpe R.M., and Wallace W.H. Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer. Hum Reprod 17 (2002) 1715-1723
2. In: Ries L.A.G., Miller B.A., Hankey B.F., Kosary C.L., Harras A., and Edwards B.K. (Eds). Seer cancer statistics review, 1973-1991: tables and graphs (1994), NIH Publ, National Cancer Institute, Bethesda 94-2789
3. Robison L.L., Green D.M., Hudson M., Meadows A.T., Mertens A.C., Packer R.J., Sklar C.A., Strong L.C., Yasui Y., and Zeltzer L.K. Long-term outcomes of adult survivors of childhood cancer. Cancer 104 (2005) 2557-2564
4. Byrne J., Rasmussen S.A., Steinhorn S.C., Connelly R.R., Myers M.H., Lynch C.F., Flannery J., Austin D.F., Holmes F.F., Holmes G.E., Strong L.C., and Mulvihill J.J. Genetic disease in offspring of long-term survivors of childhood and adolescent cancer. Am J Hum Genet 62 (1998) 45-52
5. Thomson A.B., Campbell A.J., Irvine D.C., Anderson R.A., Kelnar C.J., and Wallace W.H. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 360 (2002) 361-367
6. Wallace W.H.B. Growth and endocrine function following the treatment of childhood malignant disease. In: Pinkerton C.R., and Plowman P.N. (Eds). Paediatric oncology: clinical practice and controversies. 2nd ed. (1997), Chapman & Hall Medical, London 706-731
7. Oberfield S.E., and Sklar C.A. Endocrine sequelae in survivors of childhood cancer. Adolesc Med 13 (2002) 161-169
8. Heikens J., Behrendt H., Adriaanse R., and Berghout A. Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease. Cancer 78 (1996) 2020-2024
9. Mackie E.J., Radford M., and Shalet S.M. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27 (1996) 74-78
10. Howell S., and Shalet S. Gonadal damage from chemotherapy and radiotherapy. Endocrinol Metab Clin North Am 27 (1998) 927-943
11. Waring A.B., and Wallace W.H. Subfertility following treatment for childhood cancer. Hosp Med 61 (2000) 550-557
12. Thomson A.B., Campbell A.J., Irvine D.C., Anderson R.A., Kelnar C.J., and Wallace W.H. Semen quality and spermatozoal DNA integrity in survivors of childhood cancer: a case-control study. Lancet 360 (2002) 361-367
13. Thomson A.B., Anderson R.A., Irvine D.S., Kelnar C.J., Sharpe R.M., and Wallace W.H. Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer. Hum Reprod 17 (2002) 1715-1723
14. Wallace W.H., Anderson R.A., and Irvine D.S. Fertility preservation for young patients with cancer: who is at risk and what can be offered?. Lancet Oncol 6 (2005) 209-218
15. Meistrich M.L., Finch M., da Cunha M.F., Hacker U., and Au W.W. Damaging effects of fourteen chemotherapeutic drugs on mouse testis cells. Cancer Res 42 (1982) 122-131
16. Kangasniemi M., Huhtaniemi I., and Meistrich M.L. Failure of spermatogenesis to recover despite the presence of a spermatogonia in the irradiated LBNF1 rat. Biol Reprod 54 (1996) 1200-1208
17. Sanders J.E., Hawley J., Levy W., Gooley T., Buckner C.D., Deeg H.J., Doney K., Storb R., Sullivan K., Witherspoon R., and Appelbaum F.R. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87 (1996) 3045-3052
18. Goldman S., and Johnson F.L. Effects of chemotherapy and irradiation on the gonads. Endocrinol Metab Clin North Am 22 (1993) 617-629
19. Watson A.R., Rance C.P., and Bain J. Long term effects of cyclophosphamide on testicular function. Br Med J 291 (1985) 1457-1460
20. Aubier F., Flamant F., Brauner R., Caillaud J.M., Chaussain J.M., and Lemerle J. Male gonadal function after chemotherapy for solid tumors in childhood. J Clin Oncol 7 (1989) 304-309
21. Anselmo A.P., Cartoni C., Bellantuono P., Maurizi-Enrici R., Aboulkair N., and Ermini M. Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP. Haematologica 75 (1990) 155-158
22. Nicholson H.S., Mulvihill J.J., and Byrne J. Late effects of therapy in adult survivors of Osteosarcoma and Ewing's Sarcoma. Med Pediatr Oncol 20 (1992) 6-12
23. Bokemeyer C., Schmoll H.J., van Rhee J., Kuczyk M., Schuppert F., and Poliwoda H. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 68 (1994) 105-110
24. Meistrich M.L., Chawla S.P., Da Cunha M.F., Johnson S.L., Plager C., Papadopoulos N.E., Lipshultz L.I., and Benjamin R.S. Recovery of sperm production after chemotherapy for osteosarcoma. Cancer 63 (1989) 2115-2123
25. Kenney L.B., Laufer M.R., Grant F.D., Grier H., and Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer 91 (2001) 613-621
26. Gerl A., Muhlbayer D., Hansmann G., Mraz W., and Hiddemann W. The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumors. Cancer 91 (2001) 1297-1303
27. Oehninger S. Strategies for fertility preservation in female and male cancer survivors. J Soc Gynecol Invest 12 (2005) 222-231
28. Howell S.J., and Shalet S.M. Effect of cancer therapy on pituitary-testicular axis. Int J Androl 25 (2002) 269-276
29. Mackie E.J., Radford M., and Shalet S.M. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol 27 (1996) 74-78
30. Wallace W.H., Shalet S.M., Lendon M., and Morris-Jones P.H. Male fertility in long-term survivors of childhood acute lymphoblastic leukaemia. Int J Androl 14 (1991) 312-319
31. Wallace W.H., Shalet S.M., Crowne E.C., Morris-Jones P.H., Gattamaneni H.R., and Price D.A. Gonadal dysfunction due to cis-platinum. Med Pediatr Oncol 17 (1989) 409-413
32. Kurdoglu B., Wilson G., Parchuri N., Ye W.S., and Meistrich M.L. Protection from radiation-induced damage to spermatogenesis by hormone treatment. Radiat Res 139 (1994) 97-102
33. Kangasniemi M., Dodge K., Pemberton A.E., Huhtaniemi I., and Meistrich M.L. Suppression of mouse spermatogenesis by a gonadotropin-releasing hormone antagonist and antiandrogen: failure to protect against radiation-induced gonadal damage. Endocrinology 137 (1996) 949-955
34. Whitehead E., Shalet S.M., Jones P.H., Beardwell C.G., and Deakin D.P. Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Arch Dis Child 57 (1982) 287-291
35. Relander T., Cavallin-Stahl E., Garwicz S., Olsson A.M., and Willen M. Gonadal and sexual function in men treated for childhood cancer. Med Pediatr Oncol 35 (2000) 52-63
36. Waxman J.H., Ahmed R., Smith D., Wrigley P.F., Gregory W., Shalet S., Crowther D., Rees L.H., Besser G.M., Malpas J.S., et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol 19 (1987) 159-162
37. Chemes H.E. Infancy is not a quiescent period of testicular development. Int J Androl 24 (2001) 2-7
38. DeMarini di 3 DeMarini DM, Brockman H.E., de Serres F.J., Evans H.H., Stankowski Jr. L.F., and Hsie A.W. Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspective. Mutat Res 220 (1989) 11-29
39. Epstein RJ di 3 Epstein RJ. Drug-induced DNA damage and tumor chemosensitivity. J Clin Oncol 8 (1990) 2062-2084
40. Hales BF di 20 Hales BF, Crosman K., and Robaire B. Increased postimplantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide. Teratology 45 (1992) 671-678
41. Barton T.S., Wyrobek A.J., Hill F.S., Robaire B., and Hales B.F. Numerical chromosomal abnormalities in rat epididymal spermatozoa following chronic cyclophosphamide exposure. Biol Reprod 69 (2003) 1150-1157
42. Templado C., Benet J., Genesca A., Navarro J., Caballin M.R., Miro R., and Egozcue J. Human sperm chromosomes. Hum Reprod 3 (1988) 133-138
43. Foresta C., Bettella A., Marin P., Galeazzi C., Merico M., and Scandellari C. Analysis of sperm aneuploidy in infertile subjects after chemotherapy treatment. Ann Ital Med Int 15 (2000) 189-194
44. Brinster R.L., and Zimmermann J.W. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci USA 91 (1994) 11298-11302
45. Clouthier D.E., Avarbock M.R., Maika S.D., Hammer R.E., and Brinster R.L. Rat spermatogenesis in mouse testis. Nature 381 (1996) 418-421
46. Schlatt S. Germ cell transplantation. Mol Cell Endocrinol 186 (2002) 163-167
47. Frederickx V., Michiels A., Goossens E., De Block G., Van Steirteghem A.C., and Tournaye H. Recovery, survival and functional evaluation by transplantation of frozen-thawed mouse germ cells. Hum Reprod 19 (2004) 948-953
48. Orwig K.E., and Schlatt S. Cryopreservation and transplantation of spermatogonia and testicular tissue for preservation of male fertility. J Natl Cancer Inst Monogr 34 (2005) 51-56
49. Honaramooz A., Snedaker A., Boiani M., Scholer H., Dobrinski I., and Schlatt S. Sperm from neonatal mammalian testes grafted in mice. Nature 418 (2002) 778-781
50. Kubota H., Avarbock M.R., and Brinster R.L. Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. Proc Natl Acad Sci USA 101 (2004) 16489-16494
51. Shetty G., and Meistrich M.L. Hormonal approaches to preservation and restoration of male fertility after cancer treatment. J Natl Cancer Inst Monogr 34 (2005) 36-39
52. Schlatt S., Rosiepen G., Weinbauer G.F., Rolf C., Brook P.F., and Nieschlag E. Germ cell transfer into rat, bovine, monkey and human testes. Hum Reprod 14 (1999) 144-150
53. Schlatt S., Foppiani L., Rolf C., Weinbauer G.F., and Nieschlag E. Germ cell transplantation into X-irradiated monkey testes. Hum Reprod 17 (2002) 55-62
54. Nagano M., Patrizio P., and Brinster R.L. Long-term survival of human spermatogonial stem cells in mouse testes. Fertil Steril 78 (2002) 1225-1233
55. Tesarik J., Bahceci M., Ozcan C., Greco E., and Mendoza C. Restoration of fertility by in-vitro spermatogenesis. Lancet 353 9152 (1999) 555-556 [no abstract available]
56. Brougham M.F., Kelnar C.J., Sharpe R.M., and Wallace W.H. Male fertility following childhood cancer: current concepts and future therapies. Asian J Androl 5 (2003) 325-337
57. Agarwal A., and Said T.M. Implications of systemic malignancies on human fertility. Reprod Biomed Online 9 (2004) 673-679
58. Schrader M., Muller M., Straub B., and Miller K. The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects. Reprod Toxicol 15 (2001) 611-617
59. Meistrich M.L., Wilson G., Brown B.W., da Cunha M.F., and Lipshultz L.I. Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas. Cancer 70 (1992) 2703-2712
60. Siimes M.A., and Rautonen J. Small testicles with impaired production of sperm in adult male survivors of childhood malignancies. Cancer 65 (1990) 1303-1306
61. Longhi A., Macchiagodena M., Vitali G., and Bacci G. Fertility in male patients treated with neoadjuvant chemotherapy for osteosarcoma. J Pediatr Hematol Oncol 25 (2003) 292-296
62. Colvin M. The comparative pharmacology of cyclophosphamide and ifosfamide. Semin Oncol 9 (1982) 2-7
63. World Health Organization. Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction (1999), Cambridge University Press, New York
64. Foresta C., Galeazzi C., Bettella A., Stella M., and Scandellari C. High incidence of sperm sex chromosomes aneuploidies in two patients with Klinefelter's syndrome. J Clin Endocrinol Metab 83 (1998) 203-205
65. Groome N.P., Illingworth P.J., O'Brien M., Pai R., Rodger F.E., Mather J.P., and McNeilly A.S. Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 81 (1996) 1401-1405
66. Illingworth P.J., Groome N.P., Byrd W., Rainey W.E., McNeilly A.S., Mather J.P., and Bremner W.J. Inhibin-B: a likely candidate for the physiologically important form of inhibin in men. J Clin Endocrinol Metab 81 (1996) 1321-1325
67. Foresta C., Garolla A., Bartoloni L., Bettella A., and Ferlin A. Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection. J Clin Endocrinol Metab 90 (2005) 152-156
68. Linet M.S., Ries L.A., Smith M.A., Tarone R.E., and Devesa S.S. Cancer surveillance series: recent trends in childhood cancer incidence and mortality in the United States. Natl Cancer Inst 91 (1999) 1051-1058
69. Robison L.L. The Childhood Cancer Survivor Study: a resource for research of long-term outcomes among adult survivors of childhood cancer. Minn Med 88 (2005) 45-49